MetLife, Inc. $MET Shares Purchased by Korea Investment CORP

Korea Investment CORP boosted its position in MetLife, Inc. (NYSE:MET) by 12.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 666,354 shares of the financial services provider’s stock after buying an additional 71,781 shares during the period. Korea Investment CORP’s holdings in MetLife were worth $54,888,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Brighton Jones LLC boosted its holdings in shares of MetLife by 9.0% in the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock valued at $347,000 after acquiring an additional 351 shares in the last quarter. Caxton Associates LLP purchased a new position in MetLife during the first quarter worth about $307,000. Empowered Funds LLC raised its holdings in MetLife by 187.6% during the first quarter. Empowered Funds LLC now owns 33,378 shares of the financial services provider’s stock worth $2,680,000 after purchasing an additional 21,771 shares in the last quarter. Sivia Capital Partners LLC acquired a new stake in MetLife in the second quarter valued at about $404,000. Finally, Golden State Wealth Management LLC boosted its holdings in MetLife by 41.9% in the 2nd quarter. Golden State Wealth Management LLC now owns 667 shares of the financial services provider’s stock valued at $54,000 after purchasing an additional 197 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

Key Stories Impacting MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife confirmed its previously announced Q1 2026 dividend on its Series A floating-rate preferred shares, $0.31501229 per share, signaling consistency in capital returns for preferred holders and helping support yield-sensitive investors. Article Title
• Positive Sentiment: MetLife and partner Crow Holdings completed the sale/trade of 210 multifamily units in Tampa — an example of active portfolio management that can free capital or crystallize gains from real-estate holdings. Article Title
• Neutral Sentiment: MetLife GCC leased ~75,000 sq ft in Noida’s Oxygen Business Park — a regional expansion/lease that speaks to business presence in India but is unlikely to move the stock materially in the near term. Article Title
• Neutral Sentiment: High-profile events at MetLife Stadium (temporary renaming/World Cup hosting coverage, ticket guides) increase brand visibility and venue revenue potential, but these items are peripheral to core insurance fundamentals. Article Title
• Neutral Sentiment: A recent piece comparing MetLife’s stock performance to peers provides context for relative valuation and momentum; useful for investors but not a direct catalyst. Article Title
• Negative Sentiment: Morgan Stanley published a pessimistic forecast for MET, which likely contributed to selling pressure and the intraday decline — analyst downgrades/price-target cuts are common drivers of short-term stock weakness. Article Title

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on MET. UBS Group increased their target price on MetLife from $94.00 to $98.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Evercore set a $95.00 price objective on MetLife in a report on Tuesday, February 10th. Keefe, Bruyette & Woods cut their price objective on MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a research report on Tuesday, November 11th. Mizuho set a $100.00 target price on MetLife in a report on Thursday, February 12th. Finally, Weiss Ratings raised shares of MetLife from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, February 20th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, MetLife presently has an average rating of “Buy” and an average price target of $94.18.

MetLife Trading Down 1.5%

Shares of MET opened at $71.83 on Monday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $85.00. The stock has a market cap of $46.84 billion, a price-to-earnings ratio of 15.28, a price-to-earnings-growth ratio of 0.66 and a beta of 0.76. The firm has a 50 day simple moving average of $77.20 and a 200-day simple moving average of $78.72.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.34 by $0.15. The firm had revenue of $52.44 billion for the quarter, compared to analyst estimates of $31.43 billion. MetLife had a return on equity of 21.81% and a net margin of 4.38%.MetLife’s revenue was up 27.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.08 EPS. Equities analysts forecast that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 3rd will be given a $0.5675 dividend. This represents a $2.27 annualized dividend and a dividend yield of 3.2%. The ex-dividend date is Tuesday, February 3rd. MetLife’s dividend payout ratio is currently 48.30%.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.